This synopsis focuses on selected guidance relating to use of diabetes technology in adults with diabetes. Recommendations address self-monitoring of blood glucose, continuous glucose monitors, and automated insulin delivery systems (Annals of Internal Medicine)
Diabetes News
Category: Audits
Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017
Since 1995, insulin pump use has continuously increased, and insulin pump therapy is now standard in patients aged <15 years. CGM use sharply rose in recent years, particularly in young children (Diabetes Care)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
Just under half a billion people are living with diabetes worldwide and the number is projected to increase by 25% in 2030 and 51% in 2045 (Diabetes Research and Clinical Practice)
IDF Diabetes Atlas: Worldwide Estimates of Incidence, Prevalence and Mortality of Type 1 Diabetes in Children and Adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Worldwide estimates of numbers of children and adolescents with type 1 diabetes continue to increase (Diabetes Research and Clinical Practice)
IDF Diabetes Atlas: Projections of the prevalence of hyperglycaemia in pregnancy in 2019 and beyond: results from the International Diabetes Federation Diabetes Atlas, 9th edition
Assuming other factors remain unchanged, our best estimation of age-adjusted HIP will show stabilisation between 2019 to 2045 of 15.8% to 16.0% (Diabetes Research and Clinical Practice)
National Diabetes Audit – Insulin Pump Report 2017-18
This report provides information on people with Type 1 diabetes on an insulin pump at National, Local Health Board (LHB), and Specialist Diabetes Service level for the audit period 2017-18 (NHS Digital)
Standards of Medical Care in Diabetes—2019
Table of Contents (Diabetes Care)
Workload impact of the Quality and Outcomes Framework for patients with diabetes: an interrupted time series in general practice
Introduction of the QOF was associated with a modest increase in clinical GP consultation rates and substantial increase in other encounters for patients with diabetes independent of changes in diabetes prevalence (British Journal of General Practice)
Diabetes Prevention Programme 2017-18
This report uses data collected alongside the National Diabetes Audit (NDA) for the period January 2017 to March 2018 in England (HQIP)
National Paediatric Diabetes Audit Report 2017-18: Care processes and outcomes
This report provides an analysis of data submitted by healthcare professionals caring for children and young people with diabetes in England and Wales over 2017/18 (HQIP)
National Diabetes Inpatient Audit (NaDIA) – 2018
The National Diabetes Inpatient Audit (NaDIA) measures the quality of diabetes care provided to people with diabetes while they are admitted to hospital whatever the cause, and aims to support quality improvement
National Diabetes Foot Care Audit, 2014-2018
The National Diabetes Foot Care Audit (NDFA) is a continuous audit of diabetic foot disease in England and Wales
Surveillance proposal consultation document
2019 surveillance of 4 diabetes guidelines (NICE)
The cost of diabetic foot ulcers and amputations to the National Health Service in England
Diabetic foot care accounts for a substantial proportion of healthcare expenditure in England, more than the combined cost of breast, prostate and lung cancers. Much of this expenditure arises through prolonged and severe ulceration (Diabetic Medicine)
National Diabetes Transition Audit, 2011 – 2017
This is the second published report for the NDTA and contains linked data from the NPDA and NDA for the audit period 2011-12 to 2016-17. The report focuses on young people with Type 1 diabetes (NHS Digital)
Prescribing for Diabetes in England – 2007/08 – 2017/18
Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2007 to March 2018 (NHS Digital)
National Diabetes Audit Report 1 Care Processes and Treatment Targets 2017-18
A full report will be published in March 2019, which will contain full key findings, recommendations and results of initial analyses into cardiovascular risk reduction and the use of statins (NHS Digital)
Factors influencing variation in participation in the National Diabetes Audit and the impact on the Quality and Outcomes Framework indicators of diabetes care management
Variation in NDA participation exists. It is suggested that some practices may need additional support when submitting data to the NDA and that NDA participation may have an impact on diabetes outcomes. However, the use of NDA outcomes as a measure of progress with diabetes care by STPs is still unclear and further investigation is needed (BMJ)
Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings
Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus (Annals of Internal Medicine)
National Paediatric Diabetes Audit Report 2016-17
National Paediatric Diabetes Audit Report 2016-17 (RCPCH)
- 1
- 2
- 3
- …
- 7
- Next Page »
Glycosmedia is also available as an App: